DK0437030T3 - Anvendelse af 4-substituerede imidazoler til nedsættelse af det intraoculære tryk - Google Patents
Anvendelse af 4-substituerede imidazoler til nedsættelse af det intraoculære trykInfo
- Publication number
- DK0437030T3 DK0437030T3 DK90312327.1T DK90312327T DK0437030T3 DK 0437030 T3 DK0437030 T3 DK 0437030T3 DK 90312327 T DK90312327 T DK 90312327T DK 0437030 T3 DK0437030 T3 DK 0437030T3
- Authority
- DK
- Denmark
- Prior art keywords
- intraocular pressure
- substituted imidazoles
- reduce intraocular
- chr3
- glaucoma
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898925618A GB8925618D0 (en) | 1989-11-13 | 1989-11-13 | Compositions and their use in lowering intraocular pressur |
GB898928288A GB8928288D0 (en) | 1989-12-14 | 1989-12-14 | Compositions and their use in lowering intraocular pressure |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0437030T3 true DK0437030T3 (da) | 1994-05-16 |
Family
ID=26296200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK90312327.1T DK0437030T3 (da) | 1989-11-13 | 1990-11-12 | Anvendelse af 4-substituerede imidazoler til nedsættelse af det intraoculære tryk |
Country Status (12)
Country | Link |
---|---|
US (1) | US5304569A (da) |
EP (1) | EP0437030B1 (da) |
JP (1) | JP3005035B2 (da) |
AT (1) | ATE104145T1 (da) |
AU (1) | AU624031B2 (da) |
CA (1) | CA2029657C (da) |
DE (1) | DE69008142T2 (da) |
DK (1) | DK0437030T3 (da) |
ES (1) | ES2051479T3 (da) |
HU (1) | HU207443B (da) |
IE (1) | IE64064B1 (da) |
NZ (1) | NZ236034A (da) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2256135B (en) * | 1991-05-31 | 1995-01-18 | Orion Yhtymae Oy | Transdermal administration of 4-substituted imidazoles |
GB9111732D0 (en) * | 1991-05-31 | 1991-07-24 | Orion Yhtymae Oy | The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs |
US5629345A (en) * | 1993-07-23 | 1997-05-13 | Vide Pharmaceuticals | Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure |
US5965620A (en) * | 1993-07-23 | 1999-10-12 | Vide Pharmaceuticals | Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure |
US20100203165A1 (en) | 2008-08-01 | 2010-08-12 | Gerald Horn | Compositions and methods for treatment of disorders or conditions of the eye |
US8952011B2 (en) | 2008-08-01 | 2015-02-10 | Eye Therapies Llc | Compositions and methods for the treatment of nasal conditions |
WO2010014552A1 (en) | 2008-08-01 | 2010-02-04 | Alpha Synergy Development, Inc. | Vasoconstriction compositions and methods of use |
US8987270B2 (en) | 2009-07-27 | 2015-03-24 | Eye Therapies Llc | Formulations of selective alpha-2 agonists and methods of use thereof |
CA2782872A1 (en) * | 2009-12-17 | 2011-06-23 | Alpha Synergy Development, Inc. | Compositions and methods for ophthalmic delivery of nasal decongestants |
US20120202863A1 (en) * | 2011-02-03 | 2012-08-09 | Gerald Horn | Compositions and methods for treatment of glaucoma |
US8445526B2 (en) | 2011-02-03 | 2013-05-21 | Glaucoma & Nasal Therapies Llc | Compositions and methods for treatment of glaucoma |
US20130096170A1 (en) | 2011-10-14 | 2013-04-18 | Hospira, Inc. | Methods of treating pediatric patients using dexmedetomidine |
US8242158B1 (en) | 2012-01-04 | 2012-08-14 | Hospira, Inc. | Dexmedetomidine premix formulation |
EP2809300A1 (en) | 2012-02-02 | 2014-12-10 | Glaucoma & Nasal Therapies LLC | Compositions and methods for treatment of glaucoma |
US8999938B2 (en) | 2013-06-21 | 2015-04-07 | Gnt Llc | Ophthalmic lipophilic drug delivery vehicle formulations |
CA2924233C (en) | 2013-10-07 | 2018-10-23 | Teikoku Pharma Usa, Inc. | Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions |
CN110585173A (zh) | 2013-10-07 | 2019-12-20 | 帝国制药美国公司 | 右旋美托咪啶经皮递送装置及其使用方法 |
WO2015054061A1 (en) | 2013-10-07 | 2015-04-16 | Teikoku Pharma Usa, Inc. | Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine |
US9717796B1 (en) | 2016-04-20 | 2017-08-01 | Slypharma, Llc | Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container |
US11160791B2 (en) | 2018-11-01 | 2021-11-02 | Medefil, Inc. | Dexmedetomidine injection premix formulation in ready to use (RTU) bags |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2069481B (en) * | 1980-02-13 | 1983-07-27 | Farmos Oy | Substituted imidazole derivatives |
CA1201066A (en) * | 1981-11-20 | 1986-02-25 | Alcon Laboratories, Inc. | N-¬3,5-dichloro-4-(2-imidazolidinylideneamino)- phenyl|-acetamide solutions for lowering intraocular pressure |
FR2549049B1 (fr) * | 1983-07-13 | 1986-06-20 | Chauvin Blache Lab | Nouvelles amidines, leur procede de preparation et leur application therapeutique |
-
1990
- 1990-10-31 US US07/607,398 patent/US5304569A/en not_active Expired - Lifetime
- 1990-11-09 CA CA002029657A patent/CA2029657C/en not_active Expired - Lifetime
- 1990-11-09 AU AU66523/90A patent/AU624031B2/en not_active Ceased
- 1990-11-09 JP JP2305890A patent/JP3005035B2/ja not_active Expired - Fee Related
- 1990-11-12 NZ NZ236034A patent/NZ236034A/xx unknown
- 1990-11-12 DE DE69008142T patent/DE69008142T2/de not_active Expired - Fee Related
- 1990-11-12 DK DK90312327.1T patent/DK0437030T3/da active
- 1990-11-12 IE IE406990A patent/IE64064B1/en not_active IP Right Cessation
- 1990-11-12 EP EP90312327A patent/EP0437030B1/en not_active Expired - Lifetime
- 1990-11-12 HU HU907099A patent/HU207443B/hu not_active IP Right Cessation
- 1990-11-12 ES ES90312327T patent/ES2051479T3/es not_active Expired - Lifetime
- 1990-11-12 AT AT90312327T patent/ATE104145T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU624031B2 (en) | 1992-05-28 |
CA2029657A1 (en) | 1991-05-14 |
AU6652390A (en) | 1991-05-16 |
HUT56351A (en) | 1991-08-28 |
IE64064B1 (en) | 1995-07-12 |
EP0437030B1 (en) | 1994-04-13 |
ATE104145T1 (de) | 1994-04-15 |
IE904069A1 (en) | 1991-05-22 |
EP0437030A3 (en) | 1991-10-30 |
US5304569A (en) | 1994-04-19 |
HU207443B (en) | 1993-04-28 |
CA2029657C (en) | 2002-06-18 |
DE69008142D1 (de) | 1994-05-19 |
JPH03170423A (ja) | 1991-07-24 |
DE69008142T2 (de) | 1994-07-21 |
JP3005035B2 (ja) | 2000-01-31 |
HU907099D0 (en) | 1991-05-28 |
EP0437030A2 (en) | 1991-07-17 |
ES2051479T3 (es) | 1994-06-16 |
NZ236034A (en) | 1993-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0437030T3 (da) | Anvendelse af 4-substituerede imidazoler til nedsættelse af det intraoculære tryk | |
DK9185D0 (da) | Dihydropyridazinonderivater og fremgangsmaade til fremstilling deraf | |
AU538424B2 (en) | Piperazino phenylindane | |
EP0354777A3 (en) | 3-(4-piperidine)-5-(2-sulfonylaminoethyl) indole derivatives | |
FI920023A0 (fi) | Heteroarylpiperazinfoereningar som antipsykotiska aemnen. | |
PL309874A1 (en) | Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives | |
NO161564C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-oxadiazolylderivater. | |
FI944823A (fi) | Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa | |
MX9206930A (es) | Nuevos compuestos | |
DK0420224T3 (da) | Anthihepatopatisk middel | |
DK0556813T3 (da) | Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler | |
DK0489379T3 (da) | 5-Amino-5,6,7,8-tetrahydroquinoliner og beslægtede forbindelser, en fremgangsmåde til deres fremstilling og deres anvendels | |
IT1313583B1 (it) | Derivati 2-amminotetralinici per la terapia del glaucoma. | |
ATE79259T1 (de) | Prophylaktische und heilende zusammensetzung enthaltende eine 8-chlorbenzothiazepin-verbindung und dessen verwendung. | |
DK0952157T3 (da) | 9a, 11b-dehydroderivater af 9-oxim-3-keto-6-0-methylerythromycin | |
DK105183D0 (da) | Fremgangsmade til fremstilling af 1,4-diaminocyclitolderivater | |
DE3772850D1 (de) | Thiadiazinon-derivate. |